semaglutide weight loss clinic walnut creek Management with Hormone & GLP-1 Weight Loss

p = 0.002) (35)

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk A large peer-reviewed study published in the British Medical Journal on July 22, 2026, has found that adults using GLP-1 receptor agonist drugs including semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) had a significantly higher rate of clinically recorded hair loss compared with people taking two other commonly prescribed diabetes medications

If you have hypothyroidism or hyperthyroidism, ensure these conditions are well-controlled before starting GLP-1 therapy

For those uninsured, we explore all possible avenues to lower costs, ensuring treatment is affordable

This portends the synergistic activation of the pathway when both drugs are used together